Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis.

Lu CZ, Lu L, Hao ZS, Xia DG, Qain J, Arnason BG.

J Neuroimmunol. 1993 Mar;43(1-2):145-9.

PMID:
8384634
2.
3.
4.

Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.

Fujii Y, Hashimoto J, Monden Y, Ito T, Nakahara K, Kawashima Y.

J Immunol. 1986 Feb 1;136(3):887-91.

PMID:
2416838
5.

IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.

Blaes F, Beeson D, Plested P, Lang B, Vincent A.

Ann Neurol. 2000 Apr;47(4):504-10.

PMID:
10762162
6.

Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.

Link H, Olsson O, Sun J, Wang WZ, Andersson G, Ekre HP, Brenner T, Abramsky O, Olsson T.

J Clin Invest. 1991 Jun;87(6):2191-6.

7.

Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis.

Yoshikawa H, Satoh K, Yasukawa Y, Yamada M.

Acta Neurol Scand. 2001 Jan;103(1):53-8.

PMID:
11153889
8.

Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.

Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J.

Ann Neurol. 1991 Oct;30(4):550-7.

PMID:
1665051
9.

A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.

Ponseti JM, Caritg N, Gamez J, López-Cano M, Vilallonga R, Armengol M.

Expert Opin Biol Ther. 2009 Jan;9(1):1-8. doi: 10.1517/14712590802588831 .

PMID:
19063688
10.

Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.

Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV.

Neurology. 1986 May;36(5):618-21.

PMID:
3486379
11.

Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.

Moulian N, Bidault J, Truffault F, Yamamoto AM, Levasseur P, Berrih-Aknin S.

Blood. 1997 May 1;89(9):3287-95.

12.

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A.

Nat Med. 2001 Mar;7(3):365-8.

PMID:
11231638
13.

Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis.

Sharshar T, Lacroix-Desmazes S, Mouthon L, Kaveri S, Gajdos P, Kazatchkine MD.

Eur J Immunol. 1998 Aug;28(8):2344-54.

14.
15.

Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay.

Gotti C, Balestra B, Mantegazza R, Tzartos S, Moretti M, Clementi F.

Muscle Nerve. 1997 Jul;20(7):800-8.

PMID:
9179151
16.
17.

Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.

Vincent A, Newsom-Davis J, Newton P, Beck N.

Neurology. 1983 Oct;33(10):1276-82.

PMID:
6684222
18.

Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.

Cole RN, Reddel SW, Gervásio OL, Phillips WD.

Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371.

PMID:
18384168
19.

The B-cell repertoire in myasthenia gravis includes all four acetylcholine receptor subunits.

Wang WZ, Fredrikson S, Qiao J, Osterman PO, Link H.

Acta Neurol Scand. 1998 Dec;98(6):422-6.

PMID:
9875621
20.

Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor.

Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E.

Neurology. 1997 Jun;48(6):1638-42.

PMID:
9191780

Supplemental Content

Support Center